Organization
NewLink Genetics Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
NewLink Genetics Corp.
... AMES, Iowa, Nov. 14, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced the appointment of Eugene P. Kennedy, M.D., FACS, ...
... AMES, Iowa, Nov. 13, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) will participate in the following investor conferences this week: ...
... If you want a Stock Review on CYTX, SRNE, MRNS, or NLNK then come over tohttp://dailystocktracker.com/register/and sign up for your free customized report. For ...
... AMES, Iowa, Nov. 02, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the third quarter ...
... AMES, Iowa, Oct. 30, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that indoximod, its leading drug development candidate, was ...
... AMES, Iowa, Oct. 20, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will release its third quarter ...
... pre-clinical stage of immunotherapy drug development include:Endonovo Therapeutics(OTC: ENDV),Pulse Biosciences, Inc.(NASDAQ: PLSE),NewLink Genetics Corporation(NASDAQ: NLNK),andInovio Pharmaceuticals, Inc.(NASDAQ: INO),Vical Incorporated(NASDAQ: VICL). Endonovo Therapeutics(OTCQB: ENDV) Market Cap: ...
... cancer. The index committee has added Gilead Sciences (Nasdaq: GILD) and NewLink Genetics (Nasdaq: NLNK). They replace Amgen (Nasdaq: AMGN) and Kite Pharma (Nasdaq: KITE), ...
... If you want a Stock Review on MRNS, NLNK, AKCA, or AMGN then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... AstraZeneca struck a deal to trial its PD-L1 drug in combination with NewLink Genetics’ IDO pathway inhibitor. And more. Nick Taylor 1. Eligo raises $20M ...
... AstraZeneca has struck a deal to combine its anti-PD-L1 drug with NewLink Genetics’ IDO pathway inhibitor. The collaborators will jointly fund a phase 2 ...
... NewLink Genetics Corporation (Nasdaq: NLNK) today announced that it has entered into a clinical collaboration ...
... notice of immediately include:Propanc Biopharma, Inc.(OTC: PPCB), Kura Oncology, Inc.(NASDAQ: KURA), NewLink Genetics Corporation(NASDAQ: NLNK), Stemline Therapeutics, Inc.(NASDAQ: STML),and Verastem, Inc.(NASDAQ: VSTM). Propanc Biopharma, Inc.(OTCQB: ...
... NewLink Genetics Corporation (NASDAQ: NLNK) today announced updated data from the ongoing Phase 2 NLG2103 ...
... AMES, Iowa, Aug. 29, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will participate in the following ...
... NewLink Genetics Corporation has reported that net loss for the second quarter ended June ...
... AMES, Iowa, July 28, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the second quarter of ...
... NewLink Genetics Corporation has dosed the first patient in the Phase I study of ...
... AMES, Iowa, July 27, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced first patient dosed in the Phase 1 study ...
... If you want a Stock Review on NLNK, OCRX, OCUL or OMER then come over tohttp://dailystocktracker.com/register/and sign up for your ...
... AMES, Iowa, July 10, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it has received a Notice of Allowance ...
... AMES, Iowa, July 07, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), today announced that it will release its second quarter ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤